Latest Report On Alzheimer’s Drugs Market To Exhibit 8.54% CAGR From 2015 To 2020 Due To Growing Prevalence Of Alzheimer’s Disease

mrrbiz has announced the addition of ‘Global Alzheimers Drug Market: Trends, Opportunities And Forecasts (2015-2020) (By Type – Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: 65 Years, 65 Years Age; By Region; Global Dementia Market)’, a report exploring the probable performance curve of the global Alzheimer’s drugs market from 2015 to 2020.

The market for Alzheimer’s drugs has enjoyed a robust growth rate over the last decade, due to the increasing amounts spent on healthcare all over the world. With rising industrialization and urbanization in developing countries, consumers have become more prosperous, leading to an increase in the amount spent on healthcare.

The rising prevalence of neurological disorders, particularly among the geriatric population, has also been responsible for the high growth rate witnessed by the Alzheimer’s drugs market. Due to various environmental factors, as well as a rise in our ability to precisely diagnose neurological conditions, the incidence of Alzheimer’s disease has risen at a steady rate in the past few decades, leading to a corresponding rise in the demand for Alzheimer’s drugs.

In addition to the increase in expenditure on curing it, increasing efforts from government and private bodies to raise awareness about neurological disorders have also resulted in high demand from the global Alzheimer’s drugs market. Earlier, neurological diseases were shrouded in mystery, due to their unknown nature and etymology, but increasing research efforts aimed at understanding the causation and treatment of neurological diseases has resulted in the steady growth rate of the Alzheimer’s drugs market.

In the coming years, the market for Alzheimer’s drugs is expected to be driven by the rising number of patients affected by the disease. The number of medical facilities treating Alzheimer’s and other neurodegenerative diseases is also expected to rise in the coming years, propelling the global Alzheimer’s drugs market.

For Sample Copy, click here:

According to the report, the global Alzheimer’s drugs market is expected to exhibit a robust CAGR of 8.54% from 2015 to 2020 as a result of a cumulative effect of the aforementioned driving factors.

The report lists the Alzheimer’s drugs in the market according to the respective stage of Alzheimer’s disease (according to the Reisberg scale) in which they are used. Regionally, the Asia Pacific market for Alzheimer’s drugs is expected to remain the leading segment of the global Azheimer’s drugs market in the aforementioned forecast period. The Asia Pacific market contributed the most revenue to the global Alzheimer’s drugs market in 2014, as a result of the growing prevalence of neurodegenerative disorders in the region and the increasing prosperity of the average patient, which allows them to utilize advanced treatments.

The report also provides details about the market operation of key players in the global Alzheimer’s drugs market, including Biotie Therapies, Acadia Pharmaceuticals, Axovant Sciences Ltd., and Novartis International AG.

To order report Call Toll Free: 866-997-4948 or send an email on

Leave a Reply

Designed by
Powered by